These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12070150)

  • 21. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New functional activities for the p21 family of CDK inhibitors.
    LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
    Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation.
    Fukumoto S; Koyama H; Hosoi M; Yamakawa K; Tanaka S; Morii H; Nishizawa Y
    Circ Res; 1999 Nov; 85(11):985-91. PubMed ID: 10571528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
    Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
    Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Toyoshima H; Hunter T
    Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
    Prall OW; Rogan EM; Musgrove EA; Watts CK; Sutherland RL
    Mol Cell Biol; 1998 Aug; 18(8):4499-508. PubMed ID: 9671459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
    Diehl JA; Sherr CJ
    Mol Cell Biol; 1997 Dec; 17(12):7362-74. PubMed ID: 9372967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
    Paternot S; Coulonval K; Dumont JE; Roger PP
    J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
    EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
    Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
    Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells.
    Chang F; McCubrey JA
    Oncogene; 2001 Jul; 20(32):4354-64. PubMed ID: 11466616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
    Matsuoka M; Kato JY; Fisher RP; Morgan DO; Sherr CJ
    Mol Cell Biol; 1994 Nov; 14(11):7265-75. PubMed ID: 7935441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
    Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
    Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
    EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.